Maria A Streltsova
Overview
Explore the profile of Maria A Streltsova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alekseeva N, Boyko A, Shevchenko M, Grechikhina M, Streltsova M, Alekseeva L, et al.
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457710
The functional activity of a certain tumor determines the effectiveness of primary NK cells and NK-92 cell line-based cancer therapy; their therapeutic effectiveness against different tumors can vary. This work...
2.
Streltsova M, Palamarchuk A, Vavilova J, Ustiuzhanina M, Boyko A, Velichinskii R, et al.
Curr Pharm Des
. 2024 Aug;
30(37):2947-2958.
PMID: 39136515
Background: The growing attention to NK cells for cancer cell therapy is associated with the need to establish highly efficient protocols for their genetic modification, particularly by retroviral transduction. Objective:...
3.
Kust S, Ustiuzhanina M, Streltsova M, Shelyakin P, Kryukov M, Lutsenko G, et al.
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38731828
HLA-DR-positive NK cells, found in both healthy individuals and patients with different inflammatory diseases, are characterized as activated cells. However, data on their capacity for IFNγ production or cytotoxic response...
4.
Palamarchuk A, Kovalenko E, Streltsova M
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540262
The NK cell exhaustion state evolving during extensive and prolonged cultivation is still one of the limitations of NK cell approaches. In this research, we transduced NK cells with the...
5.
Ustiuzhanina M, Streltsova M, Timofeev N, Kryukov M, Chudakov D, Kovalenko E
Cells
. 2024 Mar;
13(6.
PMID: 38534374
NK cells play a decisive role in controlling hCMV infection by combining innate and adaptive-like immune reactions. The hCMV-derived VMAPRTLFL (LFL) peptide is a potent activator of NKG2C NK cells....
6.
Alekseeva N, Streltsova M, Vavilova J, Ustiuzhanina M, Palamarchuk A, Boyko A, et al.
Pharmaceutics
. 2024 Jan;
16(1).
PMID: 38276503
Human cytomegalovirus (HCMV)-specific adaptive NK cells are capable of recognizing viral peptides presented by HLA-E on infected cells via the NKG2C receptor. Using retroviral transduction, we have generated a K562-cell-based...
7.
Bogdanov I, Streltsova M, Kovalenko E, Sapozhnikov A, Panteleev P, Ovchinnikova T
Biomolecules
. 2023 Sep;
13(9).
PMID: 37759716
The only human cathelicidin, LL-37, is a host defense antimicrobial peptide with antimicrobial activities against protozoans, fungi, Gram(+) and Gram(-) bacteria, and enveloped viruses. It has been shown in experiments...
8.
Boyko A, Ustiuzhanina M, Vavilova J, Streltsova M, Kust S, Siniavin A, et al.
Vaccines (Basel)
. 2023 Jun;
11(6).
PMID: 37376436
A highly effective humoral immune response induced by the Sputnik V vaccine was demonstrated in independent studies, as well as in large-scale post-vaccination follow-up studies. However, the shifts in the...
9.
Vavilova J, Ustiuzhanina M, Boyko A, Streltsova M, Kust S, Kanevskiy L, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37240393
The effectiveness of the antiviral immune response largely depends on the activation of cytotoxic T cells. The heterogeneous group of functionally active T cells expressing the CD56 molecule (NKT-like cells),...
10.
Palamarchuk A, Kovalenko E, Streltsova M
Biomedicines
. 2023 May;
11(4).
PMID: 37189709
Telomerase reverse transcriptase (TERT), a core part of telomerase, has been known for a long time only for its telomere lengthening function by reverse transcription of RNA template. Currently, TERT...